JDD Issue Highlights | April 2022
The April 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from injectable fillers, botulinum toxin in hidradenitis suppurativa, cannabis and cannabinoid product use, to psoriasis, melasma, onychomycosis and everything in between, we share this month’s issue highlights straight from the JDD …
The April 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from injectable fillers, botulinum toxin in hidradenitis suppurativa, cannabis and cannabinoid product use, to psoriasis, melasma, onychomycosis and everything in between, we share this month’s issue highlights straight from the JDD … 
The Journal of Drugs in Dermatology kicks off 2022 with an outstanding line up of editorials, original articles, and case reports focusing on aesthetic treatments. Straight from the Editor’s desk, we share this month’s issue highlights:
Authors establish that the test device is non-inferior to the comparator in Safety and Effectiveness of a Novel Hyaluronic Acid Gel for Lip Augmentation.
… 
Authors Adam J. Friedman MD, Kimia Momeni BS, and Mikhail Kogan MD present a case of a young man with psoriasis managed with topical cannabinoids.
Introduction
The interest in use of medical cannabis for chronic dermatologic conditions such as psoriasis, eczema, and acne has been growing mostly owing to rapidly emerging decriminalization across the country and impressive commercially driven popu … 
As part of the recent 2020 Integrative Dermatology Symposium, Dr. Jason Hawkes, Associate Clinical Professor of Dermatology at UC Davis, provided a fantastically comprehensive primer on the management of psoriasis in the COVID-19 era. Read on for important treatment recommendations and insights to improve your clinical practice!
As an introduction, Dr. Hawkes emphasized that psoriasis remains a … 